Advertisement

Topics

The Lustgarten Foundation for Pancreatic Cancer Research Company Profile

14:32 EDT 18th August 2017 | BioPortfolio

Founded in 1998 by Cablevision executive Marc Lustgarten, with Cablevision chairman Charles Dolan and CEO James Dolan, The Lustgarten Foundation is the nation's largest private, non-profit supporter of pancreatic cancer research, providing more than $20 million to date. The Foundation provides patient information and manages a national public awareness campaign. To learn more and to see Dr. Pausch's PSA, visit www.lustgarten.org.


News Articles [8482 Associated News Articles listed on BioPortfolio]

Stand Up To Cancer, Lustgarten Foundation Award $2M to Pancreatic Cancer Research Team

Stand Up To Cancer has partnered with the Lustgarten Foundation for Pancreatic Cancer Research to sponsor a translational research team focused on applying chimeric antigen receptor T cell (CAR-T) the...

Lustgarten Foundation To Commit $40 Million To Pancreatic Cancer Research In 2017-18

WOODBURY, N.Y., July 13, 2017 /PRNewswire-USNewswire/ -- The Lustgarten Foundation announced today that it will commit an unprecedented $40 million in 2017-18 through its new Translational Clinical Pr...

The Lustgarten Foundation for Pancreatic Cancer Research Release: Mechanism Of Metastasis Is Discovered In Pancreatic Cancer

  Life Sciences Jobs   ...

Lustgarten Foundation Funded Research Finds T Cell Proximity To Pancreatic Cancer Cells Correlates With Increased Patient Survival

BETHPAGE, N.Y., May 1, 2017 /PRNewswire-USNewswire/ -- Lustgarten Foundation's funded research found that spatial distribution of cytotoxic T-cells in proximity to pancreatic ductal adenocarcinom...

Mechanism of metastasis is discovered in pancreatic cancer

WOODBURY, N.Y., July 27, 2017 /PRNewswire-USNewswire/ -- Lustgarten Foundation funded research discovered a mechanism of metastasis in pancreatic cancer, and perhaps, other cancer types as well. The F...

Lustgarten Foundation Hosts Record Breaking Event in Westchester

BETHPAGE, N.Y., April 24, 2017 /PRNewswire-USNewswire/ -- The Westchester community rallied around neighbors devastated by pancreatic cancer yesterday and raised an unprecedented amount of over $900,0...

The Lustgarten Foundation for Pancreatic Cancer Research Release: FDA Approves Pembrolizumab for Pancreatic Cancers With Mismatch Repair Deficiency

  Life Sciences Jobs   ...

New SU2C-Lustgarten Foundation team aims to apply CAR T-cell therapy to pancreatic cancer

(American Association for Cancer Research) Stand Up To Cancer is supporting a new translational research team to explore how a type of immunotherapy that has been very successful in blood cancers can ...

PubMed Articles [12580 Associated PubMed Articles listed on BioPortfolio]

Pancreatic cancer microenvironment.

Pancreatic cancer remains one of the deadliest solid tumors in humans and an unsolved problem of today's medicine. Experimental studies reveal that the heterogeneous and complex pancreatic cancer micr...

Treatment of pancreatic insufficiency using pancreatic extract in patients with advanced pancreatic cancer: a pilot study (PICNIC).

Survival with advanced pancreatic cancer is less than 12 months. Pancreatic exocrine insufficiency may contribute to pancreatic cancer-related cachexia, via nutrient malabsorption. We aimed to determ...

KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway.

Pancreatic cancer is highly malignant and characterised by rapid and uncontrolled growth. While some of the important regulatory networks involved in pancreatic cancer have been determined, the cancer...

Accelerating Progress in the Fight Against Pancreatic Cancer Proceedings of the 2017 Leo and Anne Albert Symposium for Pancreatic Cancer Research.

Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review.

The role of conventional radiotherapy in the management of pancreatic cancer has yet to be elucidated. Over the past decade, stereotactic body radiotherapy (SBRT) has emerged as a novel therapeutic op...

Clinical Trials [8967 Associated Clinical Trials listed on BioPortfolio]

EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer

This is a single-centre, prospective, non-randomised research study. The research team will investigate the feasibility of assessing primary human pancreatic tissue for changes to T lympho...

Pancreatic Cancer Registry: For Any Person With a Personal or Family History

The NFPTR was established in 1994 to find the causes of pancreatic cancer. In brief, the investigators are interested in both the genetic and non-genetic causes of pancreatic cancer. The i...

Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer

The purpose of this research study is to try to define the highest doses of temsirolimus and gemcitabine that can be used safely in combination to treat advanced pancreatic cancer. Gemcita...

K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability

This study is an open and single-center Phase I clinical research on patients with advanced pancreatic cancer, for evaluating their adverse reactions or tolerance to K-001, so as to determ...

A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response

Patients with pancreatic cancer are treated with combinations of surgery, radiation therapy and chemotherapy, depending on the location of the cancer and other individual patient health fa...

Companies [3808 Associated Companies listed on BioPortfolio]

The Lustgarten Foundation for Pancreatic Cancer Research

Founded in 1998 by Cablevision executive Marc Lustgarten, with Cablevision chairman Charles Dolan and CEO James Dolan, The Lustgarten Foundation is the nation's largest private, non-profit support...

The Lustgarten Foundation

The Lustgarten Foundation, based in Bethpage, New York, is America's largest private foundation dedicated solely to funding pancreatic cancer research. Founded in 1998, the Foundation provides critica...

Sky Foundation, Inc.

After being diagnosed with pancreatic cancer in 2007 and responding well to treatment, Kasselman established Sky Foundation to fund research for the Sky Foundation Pancreatic Cancer Research Fund at t...

World Pancreatic Cancer Coalition

The World Pancreatic Cancer Coalition is an international group of pancreatic cancer patient advocacy groups with a mission to drive transformational change for all those affected...

Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organizat...

More Information about "The Lustgarten Foundation for Pancreatic Cancer Research" on BioPortfolio

We have published hundreds of The Lustgarten Foundation for Pancreatic Cancer Research news stories on BioPortfolio along with dozens of The Lustgarten Foundation for Pancreatic Cancer Research Clinical Trials and PubMed Articles about The Lustgarten Foundation for Pancreatic Cancer Research for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Lustgarten Foundation for Pancreatic Cancer Research Companies in our database. You can also find out about relevant The Lustgarten Foundation for Pancreatic Cancer Research Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record